Washington, June 23 : A new drug could be instrumental in shrinking tumours in lung cancer patients, according to a new study.
The new drug, crizotinib, under development by Pfizer, showed dramatic results in reducing lung cancer tumours in some patients during Phase I and II clinical trials.
Phase I/II clinical trials demonstrated that 57 percent of [...]